[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365974-105":59,"doc-detail-365974-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","minimally-invasive-diagnosis-of-precancerous-cervical-lesions-using-single-cell-peripheral-immune-atlas","Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas","","CyTOF-based peripheral immune profiling enables minimally invasive detection of cervical precancer and cancer by analyzing disease-specific immune signatures in participants with varying cervical lesions. A diagnostic model built on 23 immune features achieves about 91% sensitivity and specificity for CIN2/3 and cancer detection, with stronger performance in HPV16/18-positive women. A separate model for HPV-positive participants reaches higher accuracy, including 99% sensitivity and 100% specificity for HPV16/18-associated cases. Independent cohort validation further supports the approach, which outperforms TCT screening and supports improved screening and triage strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/minimally-invasive-diagnosis-of-precancerous-cervical-lesions-using-single-cell-peripheral-immune-atlas/365974/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/minimally-invasive-diagnosis-of-precancerous-cervical-lesions-using-single-cell-peripheral-immune-atlas/365974.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the study detect precancerous cervical lesions and cancer?","Question",{"text":113,"@type":114},"It uses CyTOF-based peripheral immune profiling to identify disease-specific immune signatures from participants with varying cervical lesions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What diagnostic performance is reported for the main model?",{"text":118,"@type":114},"The CIN2+ model shows approximately 91% sensitivity and specificity for detecting CIN2/3 and cancer, with strong results in HPV16/18-positive women.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the approach compare with TCT screening in validation?",{"text":122,"@type":114},"Both immune-based models outperform TCT screening in independent cohort validation, supporting improved screening and triage using a minimally invasive strategy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},365974,1790535869,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Article  \nMinimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas  \nAuthors  \nJunfen Xu, Qinghua Ji,  \nQuanming Kong, ..., Xiao Li, Weiwei Yin, Hui Wang  \nCorrespondence  \n[5198008@zju.edu.cn](5198008@zju.edu.cn) (X.L.),  \n[xjfzu@zju.edu.cn](xjfzu@zju.edu.cn) (J.X.),  \n[wwyin@zju.edu.cn](wwyin@zju.edu.cn) (W.Y.),  \n[wang71hui@zju.edu.cn](wang71hui@zju.edu.cn) (H.W.)  \nIn brief  \nThis study presents a CyTOF-based peripheral immune profiling method that accurately detects cervical precancer and cancer. Diagnostic models show high accuracy, especially in HPV16/18-  \npositive women, and are validated in an independent cohort. The findings support a non-invasive strategy to improve cervical cancer screening and triage.  \n• CIN2+ model shows ∼91% sensitivity and specificity for CIN2/3 and cancer detection  \n• HPV+ model detects HPV16/18+ cases with 99% sensitivity and 100% specificity  \n• Both models outperform TCT screening in independent cohort validation  \nXu et al., 2025, Cell Reports Medicine 6, 102149  \nJune 17, 2025 © 2025 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2025.102149](https://doi.org/10.1016/j.xcrm.2025.102149)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nMinimally invasive diagnosis of precancerous cervical lesions using single-cell  \nperipheral immune atlas  \nJunfen Xu,1,2,3,8,* Qinghua Ji,4,8 Quanming Kong,4 Lijuan Lv,4 Bo Zhu,5 Xiufeng Huang,6,2 Zhengyun Chen,6 Ping Xu,6 Xiao Li,2,* Weiwei Yin,7,* and Hui Wang1,2,9,*  \n1Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n2Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n3Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China  \n4Zhejiang Puluoting Health Technology Co Ltd, Hangzhou, Zhejiang, China  \n5Department of Clinical Laboratory, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n6Department of Gynecology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n7Key Laboratory for Biomedical Engineering of the Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, Zhejiang, China  \n8These authors contributed equally  \n9Lead contact  \n*Correspondence: [5198008@zju.edu.cn](5198008@zju.edu.cn) (X. L.), [xjfzu@zju.edu.cn](xjfzu@zju.edu.cn) (J.X.), [wwyin@zju.edu.cn](wwyin@zju.edu.cn) (W.Y.), [wang71hui@zju.edu.cn](wang71hui@zju.edu.cn) (H.W.) [https://doi.org/10.1016/j.xcrm.2025.102149](https://doi.org/10.1016/j.xcrm.2025.102149)  \nSUMMARY  \nCervical cancer remains a major global health concern for women. Current screening methods are either invasive or lead to low participation and over-referral for colposcopy, particularly among high-risk human papillomavirus (HPV)-positive women. This study analyzes 613 participants with varying cervical lesions using mass cytometry by time-of-flight (CyTOF) to identify disease-specific peripheral immune signatures. A diagnostic model based on 23 immune features achieves ∼91% sensitivity and specificity for detecting precancerous and cancerous lesions. A separate model for HPV-positive women shows even higher accuracy (∼93% sensitivity, ∼95% specificity), especially in HPV16/18-positive cases (99% sensitivity, 100% specificity) . In an independent validation cohort (n = 105), the model distinguishes cervical intraepithelial neoplasia (CIN) 2+ from ≤CIN1 with 86.5% sensitivity and 85.3% specificity (area under the curve [AUC] = 0.89) . These findings support peripheral immune profiling as a minimally invasive and accurate biomarker strategy for early cervical cancer screening, particularly in HPV16/18-positive women.  \nINTRODUCTION  \nCervical cancer (CC) remains a significant global health issue, listed fourth in cancer-related dea","cbCaihPEsVLweVkA","https://ap.wps.com/l/cbCaihPEsVLweVkA","pdf",11012959,"English","# Summary\n# Introduction\n## Current cervical cancer screening limitations\n## Need for accurate, less invasive triage","[{\"question\":\"How does the study detect precancerous cervical lesions and cancer?\",\"answer\":\"It uses CyTOF-based peripheral immune profiling to identify disease-specific immune signatures from participants with varying cervical lesions.\"},{\"question\":\"What diagnostic performance is reported for the main model?\",\"answer\":\"The CIN2+ model shows approximately 91% sensitivity and specificity for detecting CIN2/3 and cancer, with strong results in HPV16/18-positive women.\"},{\"question\":\"How does the approach compare with TCT screening in validation?\",\"answer\":\"Both immune-based models outperform TCT screening in independent cohort validation, supporting improved screening and triage using a minimally invasive strategy.\"}]","Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas | PDF",1790163305,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b61097b46589c8de814bb2e40cb89a25.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ffc92fc5308fa615a3c70ddf4755e4d.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c693a41f03b1d4f807b9f072c20e27ed.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd18c7eccdf5bcbd9e9030ca79eefadc.webp",980,1272]